MOH — authorised 15 May 2013
- Marketing authorisation holder: BAYER HLTHCARE
- Status: likely_approved
MOH authorised Xofigo on 15 May 2013
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 15 May 2013.
BAYER HLTHCARE holds the UAE marketing authorisation.